However, it remains ambiguous whether the observed increase in VEGFA mRNA levels in A549shHTATIP2 cells is associated with the decreased HIF2α expression upon treatment with sorafenib or due to blockade of tumor vasculature by angiogenic inhibitors that leads to the compensatory release of angiogenic inducers, such as VEGFA [48]. The gene discussed is VEGFA; the disease is neoplasm.